Progress in the elimination of hepatitis C virus infection: A population-based cohort study in Spain
- PMID: 30513107
- PMCID: PMC6279228
- DOI: 10.1371/journal.pone.0208554
Progress in the elimination of hepatitis C virus infection: A population-based cohort study in Spain
Abstract
Background: The World Health Organization set targets to eliminate hepatitis C virus (HCV) infection through detection and treatment of all cases by 2030. This study aimed to describe the progress and difficulties in the elimination of HCV infection in Navarra, Spain.
Methods: Using electronic healthcare databases, we performed a population-based prospective cohort study to describe changes in the prevalence of diagnosed active HCV infection at the beginning of 2015 and the end of 2017, the rate of new diagnoses and the rate of post-treatment viral clearance (PTVC) during this period.
Results: At the beginning of 2015 there were 1503 patients diagnosed with positive HCV-RNA, 2.4 per 1000 inhabitants, and at the end of 2017 the prevalence had decreased by 47%. In the study period, 333 (18 per 100,000 person-years) new positive HCV-RNA cases were detected, but only 76 (23%; 4.2 per 100,000 person-years) did not have anti-HCV antibodies previously detected. Prevalent cases and new diagnoses of active infection were more frequent in men, people born in 1950-1979, HIV-infected patients and in those with lower income levels. Among patients with HCV-RNA, 984 achieved PTVC (22.7 per 100 person-years). PTVC was less frequent in patients born before 1940, in immigrants and in patients with lower income levels.
Conclusions: The prevalence of diagnosed active HCV infection has dropped by almost half over three years, because the number of patients with PTVC was much higher than the number of new diagnoses. Interventions specifically targeted at population groups with less favourable trends may be necessary.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures
References
-
- European Union HCV Collaborators. Hepatitis C virus prevalence and level of intervention required to achieve the WHO targets for elimination in the European Union by 2030: a modelling study. Lancet Gastroenterol Hepatol 2017;2:325–36. 10.1016/S2468-1253(17)30045-6 - DOI - PubMed
-
- Domínguez A, Bruguera M, Vidal J, Plans P, Salleras L. Community-based sero-epidemiological survey of HCV infection in Catalonia, Spain. J Med Virol 2001;65:688–93. - PubMed
-
- Bruguera M, Forns X. Hepatitis C in Spain (In Spanish). Med Clin (Barc) 2006;127:113–7. - PubMed
-
- Bruggmann P, Berg T, Øvrehus AL, Moreno C, Brandão Mello CE, Roudot-Thoraval F, et al. Historical epidemiology of hepatitis C virus (HCV) in selected countries. J Viral Hepat 2014;21(Suppl 1):5–33. 10.1111/jvh.12247 - DOI - PubMed
-
- World Health Organization. Guidelines for the screening, care and treatment of persons with hepatitis C infection. April 2014. Available at: http://www.who.int/hiv/topics/hepatitis/en/ - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical